Stockreport

Biomea Fusion to Present Poster Presentations at ObesityWeek®2025

Biomea Fusion, Inc.  (BMEA) 
PDF SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today ann [Read more]